SynthesisScientific reports2016

TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully than that to Infliximab/Adalimumab in Spondyloarthritis.

Jing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.